Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Parra

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Antimicrobial Agents|July 19, 2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolatesCeline Vidaillac, Jorge Parra-Ruiz, Patricia Winterfield, et al.
Revista Medica De Chile|August 28, 2018
[Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases]Luis Cartier R, Jorge Parra V, Bárbara Puga, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 3, 2009
[Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment]Jorge Parra-Ruiz, Cristina Tomas-Jiménez, Leopoldo Muñoz-Medina, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2012
Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Alejandra Bravo-Molina, Alejandro Peña-Monje, et al.
Biotechnology Journal|June 2, 2020
Inorganic Porous Nanoparticles for Drug Delivery in Antitumoral TherapyJorge Parra-Nieto, María Amor García Del Cid, Iñigo Aguirre de Cárcer, et al.
Sensors (Basel, Switzerland)|June 18, 2014
A framework for a context-aware elderly entertainment support systemM Anwar Hossain, Atif Alamri, Ahmad S Almogren, et al.
BMC Microbiology|November 1, 2015
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutionsDiego Parra, Alejandro Peña-Monje, Nieves María Coronado-Álvarez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
[Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance]Natalia Chueca Porcuna, Marta Alvarez Estévez, Jorge Parra Ruiz, et al.
The Annals of Pharmacotherapy|January 27, 2004
Comment: Reasons for early abacavir discontinuation in HIV-infected patientsJorge Parra-Ruiz, Mariela Martínez-Ramírez, Leopoldo Muñoz-Medina, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Antimicrobial Agents|July 19, 2011
In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolatesCeline Vidaillac, Jorge Parra-Ruiz, Patricia Winterfield, et al.
Revista Medica De Chile|August 28, 2018
[Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases]Luis Cartier R, Jorge Parra V, Bárbara Puga, et al.
Antimicrobial Agents and Chemotherapy|August 11, 2010
Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Celine Vidaillac, Warren E Rose, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|April 3, 2009
[Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment]Jorge Parra-Ruiz, Cristina Tomas-Jiménez, Leopoldo Muñoz-Medina, et al.
The Journal of Antimicrobial Chemotherapy|July 17, 2012
Activity of linezolid and high-dose daptomycin, alone or in combination, in an in vitro model of Staphylococcus aureus biofilmJorge Parra-Ruiz, Alejandra Bravo-Molina, Alejandro Peña-Monje, et al.
Biotechnology Journal|June 2, 2020
Inorganic Porous Nanoparticles for Drug Delivery in Antitumoral TherapyJorge Parra-Nieto, María Amor García Del Cid, Iñigo Aguirre de Cárcer, et al.
Sensors (Basel, Switzerland)|June 18, 2014
A framework for a context-aware elderly entertainment support systemM Anwar Hossain, Atif Alamri, Ahmad S Almogren, et al.
BMC Microbiology|November 1, 2015
In vitro efficacy of daptomycin and teicoplanin combined with ethanol, clarithromycin or gentamicin as catheter lock solutionsDiego Parra, Alejandro Peña-Monje, Nieves María Coronado-Álvarez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|March 5, 2013
[Update on hepatitis C therapy. New drugs, treatment response monitoring and emergence of resistance]Natalia Chueca Porcuna, Marta Alvarez Estévez, Jorge Parra Ruiz, et al.
The Annals of Pharmacotherapy|January 27, 2004
Comment: Reasons for early abacavir discontinuation in HIV-infected patientsJorge Parra-Ruiz, Mariela Martínez-Ramírez, Leopoldo Muñoz-Medina, et al.
Pageof 6